Samson Medical TechnologiesSamson Medical Technologies

Samson Medical Technologies

At the Forefront of Medical Innovation

Providing innovative, clinically proven medical technologies to the Australian and New Zealand markets since 2015.

Explore Our Technologies

Industry Landscape

Global Industry Stats

Global trends in the fields of Plastic, Reconstructive, ENT, and Oral Maxillofacial (OMF) surgery highlight the rising demand for advanced technologies and techniques, particularly in the use of biologics. Biotechnology advancements are reshaping surgical methods, enabling customised solutions with enhanced safety and efficacy.

Allograft Market

$5 Bil.

Projected growth by 2027 driven by a surge in reconstructive procedures and innovations in tissue engineering.

Allografts

2.2 Mil.

Transplants performed annually worldwide — the allograft industry continues to grow at a significant pace.

Dental Grafting

2 Mil.

Procedures performed annually, driven by dental implant growth, periodontal disease management and oral reconstruction.

Rhinoplasty

850,000

Surgical rhinoplasty procedures performed globally each year — one of the top facial cosmetic surgeries worldwide.

Fat Grafting

$1.3 Bil.

Market value — increasingly popular for natural augmentation in facial and body contouring procedures.

Breast Reconstruction

2.7 Mil.

Cases annually addressing both reconstructive and enhancement needs, across 23 million cosmetic surgeries worldwide.

About Samson Medical Technologies

Committed to Patient Outcomes

Samson Medical Technologies was established in 2015 with a vision to provide innovative, clinically proven technologies to the Australian and New Zealand markets. Headquartered in Sydney, we work with some of the brightest and most skilled individuals in healthcare — augmenting their capabilities with world-class medical technologies to improve patient outcomes.

Learn More About Us